SCOTT BEAUCHAMP: Open Payments
NPI 1386278521 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 23 payments from 8 companies in 2025. Trend: 2023 $693 · 2024 $338 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 12 | $103 |
| Amgen Inc. | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| UCB, Inc. | 1 | $35 |
| Novo Nordisk Inc | 2 | $28 |
| Insulet Corporation | 1 | $19 |
| Medtronic, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: iLet Bionic Pancreas, JARDIANCE, EVENITY, Briviact, Ozempic, Omnipod, TEPEZZA, MINIMED 780G.
Industry payments across TX — which companies pay providers there.
